ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,602,350 | -5.7% | 5,068,233 | 0.0% | 4.04% | -57.7% |
Q2 2023 | $8,058,490 | +121.6% | 5,068,233 | 0.0% | 9.56% | +26.1% |
Q1 2023 | $3,635,950 | +23.8% | 5,068,233 | 0.0% | 7.58% | +24.7% |
Q4 2022 | $2,937,041 | -39.0% | 5,068,233 | 0.0% | 6.08% | -26.0% |
Q3 2022 | $4,815,000 | -20.8% | 5,068,233 | 0.0% | 8.21% | -12.0% |
Q2 2022 | $6,082,000 | -8.4% | 5,068,233 | 0.0% | 9.32% | +40.7% |
Q1 2022 | $6,639,000 | -25.6% | 5,068,233 | 0.0% | 6.63% | +38.9% |
Q4 2021 | $8,920,000 | -18.9% | 5,068,233 | 0.0% | 4.77% | +4.8% |
Q3 2021 | $10,998,000 | -38.0% | 5,068,233 | 0.0% | 4.55% | -22.5% |
Q2 2021 | $17,739,000 | -64.5% | 5,068,233 | 0.0% | 5.88% | -39.6% |
Q1 2021 | $49,973,000 | -7.9% | 5,068,233 | +1.3% | 9.74% | +72.8% |
Q4 2020 | $54,242,000 | -24.8% | 5,003,892 | -28.6% | 5.63% | -57.3% |
Q3 2020 | $72,140,000 | -100.0% | 7,003,892 | 0.0% | 13.20% | -37.2% |
Q2 2020 | $146,241,265,000 | +111.8% | 7,003,892 | -0.9% | 21.01% | +10.9% |
Q1 2020 | $69,056,636,000 | – | 7,068,233 | – | 18.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |